BD200 demonstrated superior uptake and cellular cytotoxicity when compared to approved drugs targeting either Trop-2 or ...

The company releases its Q1 earnings on May 5th, in less than 2 weeks, so I think it's time for me to update my reasoning and ...

GSK (LSE:GSK) secured multi region regulatory approvals in China and the European Union for depemokimab, branded as Exdensur, ...

U.S. FDA accepts and grants Priority Review for the Biologics License Application for ifinatamab deruxtecan. The application ...

Almost (but not quite) the biggest winner: Haitian Floridians. The House voted 224-204 this week to extend temporary ...

Three students at schools in Weymouth have been diagnosed with meningitis. They are understood to have contracted meningitis ...

Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.

Revolution Medicines has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...

In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses results from the OptiTROP-Lung03 study, which were presented at European Lung Cancer ...

Ahead of the historic 130th Boston Marathon, Boston Globe Media, New England's largest news organization, will deliver special content across brands and platforms that will cover and commemorate one ...